During the peak of the COVID-19 pandemic, 67.8% (n = 181) of centers prioritized between different types of pancreatic resections. Before pancreatic surgery, most centers screened patients for COVID-19 (n = 233, 87.3%), whereas some centers did not (n = 31, 11.6%). See Table 2 for the preoperative COVID-19 screening strategy. The majority of centers (n = 166, 62.2%) performed less pancreatic surgery as consequence of the COVID-19 pandemic. From these centers, the weekly numbers of pancreatic resections decreased from 3 (IQR 2–5) to 1 (IQR 0–2) (P < 0.001). In addition, 30.7% (n = 51) of responding centers performed no pancreatic surgery at all.